EARLY PROSTATE-CANCER DIAGNOSIS

被引：0
|
作者：
VALLANCIEN, G
机构：
来源：
PATHOLOGIE BIOLOGIE | 1994年 / 42卷 / 01期
关键词：
PROSTATE CANCER; EARLY DIAGNOSIS;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [31] Thinking about one's own death after prostate-cancer diagnosis
    Thorsteinsdottir, Thordis K.
    Valdimarsdottir, Heiddis
    Stranne, Johan
    Wilderang, Ulrica
    Haglind, Eva
    Steineck, Gunnar
    SUPPORTIVE CARE IN CANCER, 2018, 26 (05) : 1665 - 1673
  • [32] IN-VITRO PROPAGATED DENDRITIC CELLS FROM PROSTATE-CANCER PATIENTS AS A COMPONENT OF PROSTATE-CANCER IMMUNOTHERAPY
    TJOA, B
    ERICKSON, S
    BARREN, R
    RAGDE, H
    KENNY, G
    BOYNTON, A
    MURPHY, G
    PROSTATE, 1995, 27 (02): : 63 - 69
  • [33] Strategies for early diagnosis and prevention of prostate cancer
    Valeri, A.
    Malavaud, B.
    Desrichard, O.
    Cornu, J. -N.
    Blanchet, P.
    Dervaux, B.
    Puech, P.
    Villers, A.
    Cancel-Tassin, G.
    Cussenot, O.
    BULLETIN DU CANCER, 2010, 97 (12) : 1499 - 1515
  • [34] Early diagnosis and surgical management of prostate cancer
    Linton, DK
    Hamdy, FC
    ANNALES D UROLOGIE, 2004, 38 (04) : 137 - 147
  • [35] Applicability of biomarkers in the early diagnosis of prostate cancer
    Hessels, D
    Verhaegh, GW
    Schalken, JA
    Witjes, JA
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (04) : 513 - 526
  • [36] ADVANTAGE OF SYSTEMATIC RANDOM ULTRASOUND-GUIDED BIOPSIES, MEASUREMENT OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL AND DETERMINATION OF PROSTATE VOLUME IN THE EARLY DIAGNOSIS OF PROSTATE-CANCER
    BILLEBAUD, T
    VILLERS, A
    ASTIER, L
    BOCCONGIBOD, L
    DAUGE, MC
    SIBERT, A
    BARON, JC
    DELMAS, V
    BOCCONGIBOD, L
    EUROPEAN UROLOGY, 1992, 21 (01) : 6 - 14
  • [37] Evaluation of a question-and-answer booklet on early-stage prostate-cancer
    Feldman-Stewart, D
    Brundage, MD
    Van Manen, L
    Skarsgard, D
    Siemens, R
    PATIENT EDUCATION AND COUNSELING, 2003, 49 (02) : 115 - 124
  • [38] MAJOR ADVANTAGES OF EARLY ADMINISTRATION OF ENDOCRINE COMBINATION THERAPY IN ADVANCED PROSTATE-CANCER
    LABRIE, F
    DUPONT, A
    CUSAN, C
    GOMEZ, JL
    DIAMOND, P
    CLINICAL AND INVESTIGATIVE MEDICINE, 1993, 16 (06): : 493 - 498
  • [39] TUMOR-MARKERS IN PROSTATE-CANCER
    COOPER, EH
    ROBINSON, MRG
    WHELAN, P
    FERRO, MA
    CANCER, 1992, 70 (01) : 225 - 229
  • [40] Molecular biology of prostate-cancer pathogenesis
    Shand, Randi L.
    Gelmann, Edward R.
    CURRENT OPINION IN UROLOGY, 2006, 16 (03) : 123 - 131
12345